Helen Xu
Analyst · Glenn Krevlin
Thank you, Mr. Liu. So now, I will cover the first quarter results, 2017. First of all for highlighting first quarter 2017. The company’s operating income increased 25%, as compared with second quarter 2016. Net income increased 25%, earnings per share increased 21%, free cash flow equaled to $0.17 per share, cash balance increased to approximately $172.8 million, or around $3.69 per share, net-net cash per share equaled to $3.29 and working capital per share equaled to $4.76. Book value per share equaled to $7.68. For the first quarter results, revenues declined 5% to approximately $32.8 million from approximately $34.5 million. Cost of goods sold declined by 15%. As a result gross, margin dollars improved 18%. As a percentage of sales, gross margins increased to 38% from 31%. Sales expenses declined by 7%. Research and Development costs increased by 3%. General admin expense declined by 10%. Total expenses declined by 15%. Income from operation increased 25% to approximately $10.8 million from approximately $8.7 million. Earnings before taxes also increased by 25% to approximately $10.9 million. Net income increased by 25% to approximately $8.1 million. Earnings per share increased by 21% to $0.17 from $0.14. Mr. Xiaobin Liu, the President and CEO of company stated that, we’re extremely proud of our much improved margins, cost controls, and profitability during the seasonably slow first quarter. We believe we will continue to produce strong results during the remainder for 2017. So now, let’s look at segment results. Firstly, we will look at the Bromine segment. Revenue in this segment increased by 6% to approximately $14 million. Volume in bromine declined by 0.2%. The average selling price per ton increased 6% to $4,071 continuing the strong increases the company has been experiencing. Cost per tonne of bromine declined 10% to $2,522. Overall costs in bromine declined by 14.8% to approximately $7.8 million. With higher pricing and lower costs, gross margins increased 52.6% to approximately $6 from approximately $4. Gross margin as a percentage of sales increased to 44% from 30%. Income before taxes in the Bromine segment increased 75.4% to approximately $5.3 million. As a percentage of revenues, income was 37.9% versus 22.9%, an increase of 1500 basis points. Income after taxes increased 75% to approximately $3.9 million. As a percentage of revenues, income after tax was 28.3% versus 17.2%. We are very pleased with the results of our Bromine segment. Mr. Liu Xiaobin stated, bromine pricing continues to increase. It is even up since the end of the quarter. We expect prices to remain strong in the future. We are investing in our facilities to improve the utilization in our facility. We believe we can continue to increase both sales and profits in Bromine segment. Stricter government regulations are forcing many smaller competitors to close, which should allow us to increase our market share. While we are not making projections, Mr. Liu continued, we would like to remind investors that our Bromine segment has historically had significantly higher earnings from operations during year 2009-2011. We are very optimistic about the opportunities in this segment. Secondly, let’s look at the Crude Salt segment. Revenue in this segment increased 3% to approximately $1.8 million from approximately $1.8 million. Gross profits in crude salt were approximately $962,000 compared to $322,000, an increase of 198%. Gross margins were 53% compared to 18%. Income from operations for crude salt equaled to approximately $885,900, an increase of 289%. Income after tax was approximately $662,300, an increase of 285%. We are very pleased, Mr. Liu stated, to see a stabilization and improvement in our crude salt sector. Thirdly, let’s look at a Chemical segment. Revenue in this segment declined 12.8% to approximately $17.1 million from approximately $19.6 million. By product line, revenues in oil and gas additives decreased 15% to approximately $4.0 million. Paper manufacturing additives declined 15% to $688,000. Pesticides additives declined 16% to approximately $2.2 million. Pharmaceutical intermediaries declined 13% to approximately $7.0 million, while pharmaceutical by products declined 7% to approximately $3.2 million. This decrease was primarily attributable to the decreased sales volume of all of our chemical products due to the slowdown in the Chinese economy and the financial tightening, which has affected our customers’ industries. With regard to pricing, oil and gas, and paper additives had pricing declines of 2% and 3%, Pesticides had a 3% increase in pricing. Pharmaceutical intermediaries had a 6% increase in pricing. This was caused largely by a change in mix to slightly lower quality products. Pharmaceutically – pharmaceutical by products had a 1.4% decrease in pricing. The cost of revenues declined by 12.9% to approximately $11.6 million. Gross margins were flat at 32%. Income from operations declined 13.6% to approximately $4.9 million. Net income declined 13.7% to approximately $3.7 million. While our chemical business is still showing declines over the previous years – previous year, Mr. Liu stated, the declines were much lower than in the fourth quarter of 2016 when sales and gross profits increased 3% and 3%, respectively, as compared to the fourth quarter of 2016. Although the economy in China is still soft and although some of our customers still have capital constraints, we believe we have reached the bottom and we are starting to see real improvements. We believe we are becoming cautiously optimistic about these businesses. So now let’s look at the natural gas project in Sichuan Province. The company had signed a contract with Sichuan Heshun Natural Gas Sales Co., Ltd, its first customer for its natural gas production in Sichuan Province. It received the production quality inspection report, and trained its labors got operator certificates. We are very pleased to have secured our first contract for natural gas, stated Liu Xiaobin, the CEO. During this initial period, it’s very important that we can deliver the natural gas we are promising. We believe our first well can produce a large amount of natural gas. We further believe that there will be opportunities to drill many more wells. However, we must be careful to make sure that we can successfully deliver on all of our commitments. We do not want to take any short cuts that could jeopardize the substantial opportunity that we believe we have before us. And now let’s look at the common cash flow and balance sheet. During the first quarter of 2017, the company generated approximately $8 million from operations. This equals to approximately $0.18 per share. We spent approximately $384,700 on PPE and prepaid land leases. Free cash flow equaled to approximately $8.0 million, or $0.17 per share. Our balance sheet continues to strengthen. We ended the quarter with cash of approximately $172.8 million, or $3.69 per share. This is an increase in cash of approximately $8 – $9.0 million. Net net cash per share equaled to around $3.29. Current assets per share were $5.11, while current liabilities were $0.35 per share. As a result, working capital per share equaled to approximately $222.5 million, or $4.76 per share. Book value increased to $359.6 million, or $7.68 per share. We have maintained a flexible policy with our accounts receivable. Receivables of over 90 days old increased 16.6% to approximately $23.2 million as compared to the fourth quarter 2016. Virtually all are with customers we know very well. During this period of strong capital constraints in China, we believe it is in our interest to give our good customers at little extra leeway. Unlike many other companies, we have a balance sheet that will allow us this luxury. However, we are constantly reviewing the credit worthiness of all of our customers. Now, let’s look at the company’s capital expenditures plan in 2017 In the year 2017, we expect to spend about $10 million on drilling two to three new wells in Sichuan Province. We will also spend some money on improving our bromine and chemical production facilities. The amount of these expenditures will depend on regulations by the local government. While we do not know what new regulations will be enacted, we believe any further regulations will enhance our competitive position versus our less well-financed competitors. We are continuing to look for vertical and horizontal acquisitions. At the present time, we believe we may have the opportunity to acquire more bromine assets and factories at very attractive prices. In addition, we are considering acquisitions of companies that export chemical products. If we can acquire companies that export, we will be able to gain financial flexibility that will enable us to help improve shareholder value. Lastly, let’s look at our 2017 guidance. For the second quarter of 2017, we expect continued strong pricing in bromine. We also believe we should be able to slightly increase the volume of bromine sold. The chemical business should be slightly lower in sales and earnings than in the previous year, however, the gap should continue to close. Earnings for the quarter should be higher than those in the previous year. For the year as a whole, we expect sales to increase between 3% to 8%. Bromine should continue to be strong. The chemical business should improve and show an increase by the fourth quarter. Net Income and earnings per share should increase by at least 10%. We believe, Mr. Liu continued, there are a number of factors that could lead to larger increases in earnings, however, because many things are currently unknown, we prefer to remain conservative. So now, I will turn the call over to Mr. Liu, for closing remarks.